<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="https://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="https://www.loc.gov/MARC21/slim https://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="https://www.loc.gov/MARC21/slim">

  <leader>02518nam a2200325   4500</leader>
  <controlfield tag="001">384286</controlfield>
  <datafield tag="010" ind1=" " ind2=" ">
    <subfield code="a">9291680303</subfield>
  </datafield>
  <datafield tag="090" ind1=" " ind2=" ">
    <subfield code="a">384286</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">20070516d1997       y0pory50      ba</subfield>
  </datafield>
  <datafield tag="101" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="200" ind1=" " ind2=" ">
    <subfield code="a">New trends in synthetic drugs in the European Union</subfield>
    <subfield code="e">epidemiology and demand reduction responses</subfield>
    <subfield code="f">written by Paul Griffiths... [et al.], European Monitoring Centre for Drugs and Drug Addiction, EMCDDA</subfield>
  </datafield>
  <datafield tag="210" ind1=" " ind2=" ">
    <subfield code="a">Luxembourg</subfield>
    <subfield code="c">Office for Official Publications of the European Communities</subfield>
    <subfield code="d">1997</subfield>
  </datafield>
  <datafield tag="215" ind1=" " ind2=" ">
    <subfield code="a">135 p.</subfield>
    <subfield code="d">21 cm</subfield>
  </datafield>
  <datafield tag="225" ind1=" " ind2=" ">
    <subfield code="a">EMCDDA Insights Series</subfield>
    <subfield code="v">1</subfield>
  </datafield>
  <datafield tag="330" ind1=" " ind2=" ">
    <subfield code="a">Foreword. Acknowledgements. Introduction. The drugs - 1. Ecstasy: definition and classification; historical perspectives; dosage and route of administration; effects of ecstasy (physical effects; psychological effects; neurotoxicity). 2. Amphetamines: definition and classification; historical perspectives; dosage and route of administration; effects of amphetamines (physical effects; psychological effects; neurotoxicity). 3. LSD: definition and classification; historical perspectives; dosage and route of administration; effects of LSD (physical effects; psychological effects; neurotoxicity). New trends - 1. The social and cultural development of a new drug trend. 2. Gender issues. 3. Gay issues. 4. Commerce and the media. 5. Alcohol. 6. Poly-drug use. 7. Supply issues. The epidemiology of synthetic drugs - 1. Drug monitoring systems. 2. The prevalence of synthetic drug use in Europe. 3. Conclusion: rapid reporting systems. Demand reduction and synthetic drugs - 1. Demand reduction responses. 2. Prevention. 3. Public prevention activities. 4. Information, education and harm reduction. 5. Regulation, collaboration and conflict. 6. Guidelines and safer dancing. 7. Outreach, peer education and self-help. 8. Working with the scene. 9. Evaluation. 10. Conclusion: responses and interventions. Conclusion. Glossary. Timeline. References.</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">PREVEN&#xC7;&#xC3;O DA TOXICODEPEND&#xCA;NCIA</subfield>
    <subfield code="9">103892</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">DROGA SINT&#xC9;TICA</subfield>
    <subfield code="9">320915</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">DOEN&#xC7;A INFECCIOSA </subfield>
    <subfield code="9">100267</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">POL&#xCD;TICA DE SA&#xDA;DE</subfield>
    <subfield code="9">234372</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">POL&#xCD;TICA SOCIAL</subfield>
    <subfield code="9">234807</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">ANFETAMINA</subfield>
    <subfield code="9">343626</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">MDMA</subfield>
    <subfield code="9">344484</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">LSD</subfield>
    <subfield code="9">345302</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">OEDT</subfield>
    <subfield code="9">321506</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">UNI&#xC3;O EUROPEIA</subfield>
    <subfield code="9">224774</subfield>
  </datafield>
  <datafield tag="710" ind1=" " ind2=" ">
    <subfield code="a">EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION</subfield>
    <subfield code="9">351987</subfield>
  </datafield>
  <datafield tag="955" ind1=" " ind2=" ">
    <subfield code="x">Oferta</subfield>
  </datafield>
  <datafield tag="995" ind1=" " ind2=" ">
    <subfield code="1">0</subfield>
    <subfield code="4">PJ_19_000000000000000_D_69</subfield>
    <subfield code="5">2022-06-06</subfield>
    <subfield code="6">PJ28045</subfield>
    <subfield code="9">414167</subfield>
    <subfield code="a">PJ</subfield>
    <subfield code="c">PJ</subfield>
    <subfield code="f">PJ128045</subfield>
    <subfield code="k">PJ19.D.69</subfield>
    <subfield code="n">2022-06-06</subfield>
    <subfield code="o">0</subfield>
    <subfield code="r">MO</subfield>
    <subfield code="x">Oferta</subfield>
  </datafield>
</record>
